Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
- Author
- GADALETA, Raffaella M1 2 3 ; VAN ERPECUM, Karel J1 ; PENNA, Giuseppe7 ; LAVERNY, Gilles7 ; ADORINI, Luciano7 ; MOSCHETTA, Antonio3 ; VAN MIL, Saskia W. C2 ; OLDENBURG, Bas1 ; WILLEMSEN, Ellen C. L2 ; RENOOIJ, Willem4 ; MURZILLI, Stefania3 ; KLOMP, Leo W. J2 ; SIERSEMA, Peter D1 ; SCHIPPER, Marguerite E. I5 ; DANESE, Silvio6
[1] Department of Gastroenterology and Hepatology, UMC Utrecht, Netherlands
[2] Department of Metabolic and Endocrine Diseases, UMC Utrecht and Netherlands Metabolomics Centre, Netherlands
[3] Laboratory of Lipid Metabolism and Cancer, Consorzio Mario Negri Sud, S.ta Maria Imbaro (Ch), Italy
[4] Department of Surgery, UMC Utrecht, Netherlands
[5] Department of Pathology, UMC Utrecht, Netherlands
[6] Department of Gastroenterology, Istituto Clinico Humanitas, Milano, Italy
[7] Intercept Pharmaceuticals, Corciano (Perugia), Italy - Source
Gut. 2011, Vol 60, Num 4, pp 463-472, 10 p ; ref : 42 ref
- CODEN
- GUTTAK
- ISSN
- 0017-5749
- Scientific domain
- Gastroenterology
- Publisher
- BMJ Publishing Group, London
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Activation Entérite de Crohn Gastroentérologie Inflammation Intestin Rectocolite ulcérohémorragique Récepteur FXR Maladie inflammatoire de l'intestin Maladie inflammatoire Pathologie de l'appareil digestif Pathologie de l'intestin
- Keyword (en)
- Activation Crohn disease Gastroenterology Inflammation Gut Ulcerative colitis Farnesoid X receptor Inflammatory bowel disease Inflammatory disease Digestive diseases Intestinal disease
- Keyword (es)
- Activación Enteritis Crohn Gastroenterología Inflamación Intestino Rectocolitis ulcerohemorrágica Receptor FXR Enfermedad inflamatoria intestinal Enfermedad inflamatoria Aparato digestivo patología Intestino patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B13 Gastroenterology. Liver. Pancreas. Abdomen / 002B13B Stomach. Duodenum. Small intestine. Colon. Rectum. Anus / 002B13B03 Other diseases. Semiology
- Discipline
- Gastroenterology. Liver. Pancreas. Abdomen
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 23944138
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1136/gut.2010.212159 
https://dx.doi.org/10.1136/gut.2010.212159
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1136\/gut.2010.212159\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:120:\"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease\";s:9:\"\u0000*\u0000jtitle\";s:3:\"Gut\";s:9:\"\u0000*\u0000stitle\";s:3:\"Gut\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"463\";s:8:\"\u0000*\u0000epage\";s:3:\"472\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0017-5749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"GADALETA\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Raffaella M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:20:\"VAN ERPECUM, Karel J\";i:1;s:15:\"PENNA, Giuseppe\";i:2;s:15:\"LAVERNY, Gilles\";i:3;s:16:\"ADORINI, Luciano\";i:4;s:18:\"MOSCHETTA, Antonio\";i:5;s:20:\"VAN MIL, Saskia W. C\";i:6;s:14:\"OLDENBURG, Bas\";i:7;s:21:\"WILLEMSEN, Ellen C. L\";i:8;s:15:\"RENOOIJ, Willem\";i:9;s:18:\"MURZILLI, Stefania\";i:10;s:15:\"KLOMP, Leo W. J\";i:11;s:17:\"SIERSEMA, Peter D\";i:12;s:25:\"SCHIPPER, Marguerite E. I\";i:13;s:14:\"DANESE, Silvio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"GUTTAK\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:120:\"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:20:\"BMJ Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1136\/gut.2010.212159\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:120:\"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease\";s:9:\"\u0000*\u0000jtitle\";s:3:\"Gut\";s:9:\"\u0000*\u0000stitle\";s:3:\"Gut\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"463\";s:8:\"\u0000*\u0000epage\";s:3:\"472\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0017-5749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"GADALETA\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Raffaella M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:20:\"VAN ERPECUM, Karel J\";i:1;s:15:\"PENNA, Giuseppe\";i:2;s:15:\"LAVERNY, Gilles\";i:3;s:16:\"ADORINI, Luciano\";i:4;s:18:\"MOSCHETTA, Antonio\";i:5;s:20:\"VAN MIL, Saskia W. C\";i:6;s:14:\"OLDENBURG, Bas\";i:7;s:21:\"WILLEMSEN, Ellen C. L\";i:8;s:15:\"RENOOIJ, Willem\";i:9;s:18:\"MURZILLI, Stefania\";i:10;s:15:\"KLOMP, Leo W. J\";i:11;s:17:\"SIERSEMA, Peter D\";i:12;s:25:\"SCHIPPER, Marguerite E. I\";i:13;s:14:\"DANESE, Silvio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"GUTTAK\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:120:\"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:20:\"BMJ Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:23:\"10.1136\/gut.2010.212159\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1136\/gut.2010.212159\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:120:\"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease\";s:9:\"\u0000*\u0000jtitle\";s:3:\"Gut\";s:9:\"\u0000*\u0000stitle\";s:3:\"Gut\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"463\";s:8:\"\u0000*\u0000epage\";s:3:\"472\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0017-5749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"GADALETA\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Raffaella M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:20:\"VAN ERPECUM, Karel J\";i:1;s:15:\"PENNA, Giuseppe\";i:2;s:15:\"LAVERNY, Gilles\";i:3;s:16:\"ADORINI, Luciano\";i:4;s:18:\"MOSCHETTA, Antonio\";i:5;s:20:\"VAN MIL, Saskia W. C\";i:6;s:14:\"OLDENBURG, Bas\";i:7;s:21:\"WILLEMSEN, Ellen C. L\";i:8;s:15:\"RENOOIJ, Willem\";i:9;s:18:\"MURZILLI, Stefania\";i:10;s:15:\"KLOMP, Leo W. J\";i:11;s:17:\"SIERSEMA, Peter D\";i:12;s:25:\"SCHIPPER, Marguerite E. I\";i:13;s:14:\"DANESE, Silvio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"GUTTAK\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:120:\"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:20:\"BMJ Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1136\/gut.2010.212159\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:120:\"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease\";s:9:\"\u0000*\u0000jtitle\";s:3:\"Gut\";s:9:\"\u0000*\u0000stitle\";s:3:\"Gut\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"463\";s:8:\"\u0000*\u0000epage\";s:3:\"472\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0017-5749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"GADALETA\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Raffaella M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:20:\"VAN ERPECUM, Karel J\";i:1;s:15:\"PENNA, Giuseppe\";i:2;s:15:\"LAVERNY, Gilles\";i:3;s:16:\"ADORINI, Luciano\";i:4;s:18:\"MOSCHETTA, Antonio\";i:5;s:20:\"VAN MIL, Saskia W. C\";i:6;s:14:\"OLDENBURG, Bas\";i:7;s:21:\"WILLEMSEN, Ellen C. L\";i:8;s:15:\"RENOOIJ, Willem\";i:9;s:18:\"MURZILLI, Stefania\";i:10;s:15:\"KLOMP, Leo W. J\";i:11;s:17:\"SIERSEMA, Peter D\";i:12;s:25:\"SCHIPPER, Marguerite E. I\";i:13;s:14:\"DANESE, Silvio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"GUTTAK\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:120:\"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:20:\"BMJ Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1136\/gut.2010.212159\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:120:\"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease\";s:9:\"\u0000*\u0000jtitle\";s:3:\"Gut\";s:9:\"\u0000*\u0000stitle\";s:3:\"Gut\";s:7:\"\u0000*\u0000date\";s:4:\"2011\";s:9:\"\u0000*\u0000volume\";s:2:\"60\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"463\";s:8:\"\u0000*\u0000epage\";s:3:\"472\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0017-5749\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"GADALETA\";s:10:\"\u0000*\u0000aufirst\";s:11:\"Raffaella M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:20:\"VAN ERPECUM, Karel J\";i:1;s:15:\"PENNA, Giuseppe\";i:2;s:15:\"LAVERNY, Gilles\";i:3;s:16:\"ADORINI, Luciano\";i:4;s:18:\"MOSCHETTA, Antonio\";i:5;s:20:\"VAN MIL, Saskia W. C\";i:6;s:14:\"OLDENBURG, Bas\";i:7;s:21:\"WILLEMSEN, Ellen C. L\";i:8;s:15:\"RENOOIJ, Willem\";i:9;s:18:\"MURZILLI, Stefania\";i:10;s:15:\"KLOMP, Leo W. J\";i:11;s:17:\"SIERSEMA, Peter D\";i:12;s:25:\"SCHIPPER, Marguerite E. I\";i:13;s:14:\"DANESE, Silvio\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"GUTTAK\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:120:\"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:20:\"BMJ Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
